Aortic root replacement with a novel decellularized cryopreserved aortic homograft: postoperative immunoreactivity and early results.

[1]  J. Légaré,et al.  Suggestion for functional model to test effects of decellularization of rat aortic valve allografts on leaflet destruction and extracellular matrix remodeling. , 2004, The Journal of thoracic and cardiovascular surgery.

[2]  K. Black,et al.  Cellular remodeling of depopulated bovine ureter used as an arteriovenous graft in the canine model. , 2004, Journal of the American College of Surgeons.

[3]  M. DeRuiter,et al.  Decellularization of rat aortic valve allografts reduces leaflet destruction and extracellular matrix remodeling. , 2003, The Journal of thoracic and cardiovascular surgery.

[4]  M. Müller-Steinhardt,et al.  Evaluation of the decellularized pulmonary valve homograft (SynerGraft). , 2003, The Journal of heart valve disease.

[5]  W. Wells,et al.  Depopulated vena caval homograft: a new venous conduit. , 2003, The Journal of thoracic and cardiovascular surgery.

[6]  L. Lambert,et al.  Immunogenicity of decellularized cryopreserved allografts in pediatric cardiac surgery: comparison with standard cryopreserved allografts. , 2003, The Journal of thoracic and cardiovascular surgery.

[7]  E Wolner,et al.  Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[8]  T. Ryan,et al.  Exercise echocardiographic comparison of pulmonary autograft and aortic homograft replacements for aortic valve disease in adults. , 2003, The Journal of heart valve disease.

[9]  R. Elkins.  Is tissue-engineered heart valve replacement clinically applicable? , 2003, Current cardiology reports.

[10]  L. Bow,et al.  Decellularized cadaver vein allografts used for hemodialysis access do not cause allosensitization or preclude kidney transplantation. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[11]  M. Welters,et al.  A broad and strong humoral immune response to donor HLA after implantation of cryopreserved human heart valve allografts. , 2002, Human immunology.

[12]  Alexander Lembcke,et al.  Ross operation with a tissue-engineered heart valve. , 2002, The Annals of thoracic surgery.

[13]  M. Hazekamp,et al.  The pathology of fresh and cryopreserved homograft heart valves: an analysis of forty explanted homograft valves. , 2002, The Journal of thoracic and cardiovascular surgery.

[14]  P. Pibarot,et al.  Hemodynamic Performance at Rest and During Exercise After Aortic Valve Replacement: Comparison of Pulmonary Autografts Versus Aortic Homografts , 2002, Circulation.

[15]  A. Bogers,et al.  The presence of immune stimulatory cells in fresh and cryopreserved donor aortic and pulmonary valve allografts. , 2002, The Journal of heart valve disease.

[16]  B. Maruszewski,et al.  Presence of IgG anti-HLA antibodies in fourteen patients after cryopreserved allogenic heart valve implantation. , 2002, Transplantation proceedings.

[17]  K. Black,et al.  Recellularization of heart valve grafts by a process of adaptive remodeling. , 2001, Seminars in thoracic and cardiovascular surgery.

[18]  D. Pennell,et al.  Incidence, Location, Pathology, and Significance of Pulmonary Homograft Stenosis After the Ross Operation , 2001, Circulation.

[19]  H. Klüter,et al.  Does Histocompatibility Affect Homograft Valve Function After the Ross Procedure? , 2001, Circulation.

[20]  L. Bow,et al.  Use of cryopreserved cadaveric vein allograft for hemodialysis access precludes kidney transplantation because of allosensitization. , 2001, Journal of vascular surgery.

[21]  H. Klüter,et al.  Anti-HLA class I antibodies and pulmonary homograft function after the Ross procedure. , 2001, The Annals of thoracic surgery.

[22]  K. Black,et al.  Decellularized human valve allografts. , 2001, The Annals of thoracic surgery.

[23]  M. O'Brien,et al.  The homograft aortic valve: a 29-year, 99.3% follow up of 1,022 valve replacements. , 2001, The Journal of heart valve disease.

[24]  K. Black,et al.  Transpecies heart valve transplant: advanced studies of a bioengineered xeno-autograft. , 2000, The Annals of thoracic surgery.

[25]  J. Passage,et al.  Influence of HLA matching and associated factors on aortic valve homograft function. , 2000, The Journal of heart valve disease.

[26]  M. Yacoub,et al.  Pulmonary autograft versus aortic homograft for aortic valve replacement: interim results from a prospective randomized trial. , 2000, The Journal of heart valve disease.

[27]  W. Chitwood,et al.  Video-assisted and robotic mitral valve surgery: toward an endoscopic surgery. , 1999, Seminars in thoracic and cardiovascular surgery.

[28]  M. Yacoub,et al.  Effect of HLA mismatching and antibody status on "homovital" aortic valve homograft performance. , 1998, The Annals of thoracic surgery.

[29]  R. Guyton,et al.  Myocardial protection for off-pump coronary artery bypass surgery. , 2001, Seminars in thoracic and cardiovascular surgery.

[30]  A. Khaghani,et al.  Primary aortic valve replacement with allografts over twenty-five years: valve-related and procedure-related determinants of outcome. , 1999, The Journal of thoracic and cardiovascular surgery.

[31]  A. Yates.  The homograft aortic valve. , 1966, Acta chirurgica Scandinavica. Supplementum.